Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Aflatoxicosis Treatment Market Outlook

As per the analysis, the global aflatoxicosis treatment market is expected to secure US$ 279.5 million in 2023 and reach US$ 407.6 million by 2033. The market is estimated to secure a CAGR of 3.8% during the forecast period. Growing instances of foodborne illness are expected to play a key role in driving the market growth during the forecast period.

As per World Health Organization, aflatoxins pose a significant economic challenge by ruining more than 25% of the world’s grain annually. Developing countries like India suffer significantly owing to the lack of storage facilities, eventually resulting in exposure to toxins like aflatoxins. According to a recent National Academy of Agricultural Sciences, India study, lack of storage facility is the most important cause of post-harvest losses for all types of food in India.

However, the market can rise with growing favorable initiatives such as the SVAMITVA scheme. The scheme digitally empowers Gram Panchayats by engaging the latest surveying technologies to digitally map and record other properties. The market is projected to witness notable development in the forecast period due to such factors.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Factors Supporting Global Market Growth?

Increasing awareness about aflatoxins is expected to support the market growth during the forecast period. There have been various studies on the subject, which are expected to propel market growth in the coming period. Enhanced awareness about grain storage facilities is another salient factor supporting the market expansion in the coming period.

Developing countries are taking several initiatives to address the situation, a significant factor supporting industry growth in the forecast period. Also, modern grain storage facilities is estimated to further augment the market size in the coming time.

Additionally, stringent government rules on mycotoxin detection are expected to develop the industry in the forecast period. More than 100 countries have formal mycotoxin regulations for feed and food. EU has the most stringent rules, where several organizations and pan-European networks work to combat the challenges associated with the toxin.

In May 2006, in Kenya, an outbreak of acute aflatoxicosis was reported, where aflatoxin contamination of homegrown corn had become a recurring issue. In collaboration with the Kenya government, CDC worked on the trial of a portable, rapid aflatoxin screening tool that could be utilized in the field to recognize contaminated corn and suggest urgent corn replacement directions during an outbreak. Thus, owing to the factors above, the market is estimated to likely witness significant future growth.

What Factors are Challenging the Growth of the Global Market?

In developing countries, a lack of advanced technologies, infrastructure, and resources is expected to impede market expansion during the forecast period. Other issues associated with the market, such as scarce resources, poor management, and limited technology, may impede market growth in the future. Furthermore, the need for more support for developing countries from organizations such as the World Health Organization, the Food and Agriculture Organization, and the World Bank is likely to aggravate the situation.

However, with the rising food trade in developing countries, the market is expected to see some growth. Furthermore, rising mycotoxin outbreaks in emerging markets such as Asia and Africa are expected to offer lucrative opportunities to the market during the forecast period.

Attributes Details
Market CAGR (2023 to 2033) 3.8%
Market Valuation (2023) US$ 279.5 million
Market Valuation (2033) US$ 407.6 million
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Sales Analysis of the Aflatoxicosis Treatment Market from 2018 to 2022 Vs Market Outlook for 2023 to 2033

The global demand for Aflatoxicosis Treatment is slated to grow at a moderate CAGR of 3.8% during the forecast period, totaling over US$ 407.6 million by 2033. Increased concerns about aflatoxins are expected to contribute to market growth.

Several studies on the subject have been conducted, and they are predicted to influence market growth in the coming years. The global demand for Aflatoxicosis Treatment grew at a moderate CAGR of 2.7% with a valuation of US$ 237.1 million in 2018 and US$ 271.2 million in 2022.

Enhanced awareness regarding grain storage facilities is another salient factor facilitating the market expansion in the upcoming years. Developing countries are taking various steps to deal with the situation, a large determinant supporting industry growth during the forecast period. Furthermore, modern grain storage facilities is estimated to increase market size shortly.

Furthermore, the industry is anticipated to develop during the forecast period due to stringent government regulations on mycotoxin detection. More than 100 countries currently have formal mycotoxin regulations for feed and food.

An outbreak of acute aflatoxicosis was reported in Kenya in May 2006, where aflatoxin contamination of homegrown corn had emerged as a recurring issue.

In collaboration with the Kenyan government, the CDC tested a portable, rapid aflatoxin screening tool that could be used in the field to identify contaminated corn and suggest urgent corn suitable alternative directions during an outbreak. Thus, owing to the components above, the market also experienced significant growth in the historical period.

Region-Wise Insights

Countries Market Value Share in 2023
United States 34.4%
Germany 6.2%
Japan 3.4%
Countries Market CAGR Value in 2023
China 3.1%
India 3.5%
United Kingdom 3.3%
Australia 2.7%

Why is the Asia Pacific is Driving the Global Market?

According to the analysis, the market in the Asia Pacific is expected to develop faster and provide lucrative opportunities during the forecast period. The presence of developing countries such as India, China, and Japan has contributed to the market's growth. During the assessment period, these countries' governments impose various initiatives that can support market growth.

The Chinese government strives to ensure global food safety regulations and standards compliance. The Food Safety and Standards Authority of India (FSSAI) inspects the quality of food products in India. With the presence of such authorities in developing countries, the Asia Pacific market is likely to expand rapidly during the forecast period.

Countries like India and China are obtaining government assistance for financing and developing cutting-edge technologies. These emerging economies' regulatory bodies are using their resources to construct infrastructure and upgrade technology to create high-growth opportunities for Aflatoxicosis Treatment in Asia.

Why is North America Emerging as a Promising Market for Aflatoxicosis Treatment?

According to the analysis, the North American market is estimated to possess a 36.6% market share by 2033. The market's expansion can be due to increasing concerns about food safety and increasing awareness about toxins.

Ongoing research and development on the subject are likely to provide significant market growth opportunities. For example, Mars Inc. in the United States has launched a three-year project titled "Identification of markers and genomic regions associated with aflatoxin resistance in groundnut." This survey aims to validate the identified genes and generate diagnostic markers for molecular breeding to produce fine lines with better aflatoxin resistance.

According to a recent research report by FMI, the 'corn belt' region of the United States is estimated to likely face increased problems with aflatoxins shortly. Field corn, as opposed to sweet corn, is widely consumed in the United States and is one of the important crops, so North America is estimated to witness a huge demand for aflatoxicosis treatment in the forthcoming years.

What is the Growth Projection for the Europe Aflatoxicosis Treatment Market?

Maize is a concern for mycotoxin contamination among staple crops; mycotoxins are regulated in Europe and several other countries worldwide, and several co-occurring fungal organisms are abundantly found. With a mandate to identify emerging risks in the food and feed sectors, the European Food Safety Authority (EFSA) has identified changing patterns in mycotoxin production in cereals due to CC as a potential source of concern.

The EU has stringent rules, and several organizations and pan-European networks cooperate in combating the toxin's challenges. Aflatoxin (AF) contamination in maize is also expected to increase due to climate change (CC).

Consequently, such factors are expected to contribute to substantial growth in the European market during the forecast period. Europe is estimated to account for around 27.6% of the global market by 2033.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Start-up Ecosystem: How Key Players are Opening Frontiers for Future Growth?

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,

  • Shandong Meizheng Bio-Tech Co., Ltd. was founded in 2017. They have been producing medicines for the treatment of Aflatoxicosis.
  • Beijing Kwinbon Biotechnology Co., Ltd., founded in 2002 at China Agricultural University (CAU), is a manufacturer and retailer of Aflatoxicosis Treatment medicines and test kits.

Who are the Leading Players in Aflatoxicosis Treatment Market?

Some leading Aflatoxicosis Treatment manufacturers include Pfizer Inc., Sanofi, Abbott Laboratories, Zydus Cadilla, Glaxo Smith Kline, and Johnson and Johnson.

Because of the presence of regional and domestic players, the global market is highly competitive. To capitalize, leading enteral feeding device manufacturers implement a wide range of tactics such as new product launches and approvals, collaborations, partnerships, acquisitions, and strengthening of the distribution channel. As an example,

  • CEVA has worked for over 20 years against mycotoxins, formerly as part of SANOFI animal health division. They manufacture and provide medicines for Aflatoxicosis.
  • Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, primarily engaged in manufacturing generic drugs for aflatoxicosis treatment.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered United States, United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered
  • Treatment
  • Region
Key Companies Profiled Pfizer Inc., Sanofi, Abbott Laboratories, Zydus Cadilla, Glaxo Smith Kline, Johnson, and Johnson.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Aflatoxicosis Treatment Market by Category

By Treatment:

  • Blood Transfusion
  • Oxygen Therapy
  • Antibiotics
  • Antihistamines
  • Immunosuppressants
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

What are the Top Content Delivery Network (CDN) Companies?

Akamai, CloudFlare, and Microsoft are the top companies in the global market.

How Big is the Aflatoxicosis Treatment Market?

The global market is valued at US$ 279.5 million in 2023.

What is the Projected Size of the Aflatoxicosis Treatment Market in Ten Years?

The adoption of Aflatoxicosis treatments could be around US$ 407.6 million by 2033.

Which is the Leading Regional Market for Aflatoxicosis Treatment in Europe?

Germany dominates the region and accounted for 6.2% market share in 2022.

How Big is the Aflatoxicosis Treatment Market in the United States?

The United States Market contributed for roughly 34.4% of the global revenue in 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033

        5.3.1. Blood Transfusion

        5.3.2. Oxygen Therapy

        5.3.3. Antibiotics

        5.3.4. Antihistamines

        5.3.5. Immunosuppressants

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        7.2.1. By Country

            7.2.1.1. USA

            7.2.1.2. Canada

        7.2.2. By Treatment

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Treatment

    7.4. Key Takeaways

8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Treatment

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Treatment

    8.4. Key Takeaways

9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. UK

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Treatment

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Treatment

    9.4. Key Takeaways

10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Treatment

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Treatment

    10.4. Key Takeaways

11. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Treatment

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Treatment

    11.4. Key Takeaways

12. Key Countries Market Analysis

    12.1. USA

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2023

            12.1.2.1. By Treatment

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2023

            12.2.2.1. By Treatment

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2023

            12.3.2.1. By Treatment

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2023

            12.4.2.1. By Treatment

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2023

            12.5.2.1. By Treatment

    12.6. UK

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2023

            12.6.2.1. By Treatment

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2023

            12.7.2.1. By Treatment

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2023

            12.8.2.1. By Treatment

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2023

            12.9.2.1. By Treatment

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2023

            12.10.2.1. By Treatment

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2023

            12.11.2.1. By Treatment

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2023

            12.12.2.1. By Treatment

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2023

            12.13.2.1. By Treatment

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2023

            12.14.2.1. By Treatment

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2023

            12.15.2.1. By Treatment

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2023

            12.16.2.1. By Treatment

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2023

            12.17.2.1. By Treatment

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2023

            12.18.2.1. By Treatment

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2023

            12.19.2.1. By Treatment

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Treatment

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Pfizer Inc.

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. Sanofi

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. Zydus Cadilla

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. Abbott Laboratories

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. Glaxo Smith Kline

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. Johnson and Johnson

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. Elanco Animal Health Incoproration

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. Merck & CO. Inc

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. Virbac

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Bayer AG

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

Recommendations

Healthcare

Dysmenorrhea Treatment Market

Published : August 2023

Healthcare

Scabies Treatment Market

Published : November 2022

Explore Healthcare Insights

View Reports

Aflatoxicosis Treatment Market